What's New

Migrant women human rights defenders include women, girls, and gender-diverse persons of all ages who promote and protect the human rights of people on the move, whether they are migrants themselves or not, regardless of their migration status, and irrespective of whether they self-identify as a woman human rights defender. These recommendations are a call to action to all stakeholders to recognize and address the risks facing migrant women human rights defenders and put in place measures to promote and protect human rights unhindered so that migrants in all their diversity can live, work, and move safely and with dignity.

Transgender people often experience multiple and intersecting forms of discrimination, including in criminal justice systems. Evidence indicates that such marginalisation, criminalisation and discrimination can lead to greater vulnerability to and risk of long-term mental and physical health issues, including increased risk of HIV and other sexually transmitted infections, and experience of sexual assault. This technical brief sets out guiding principles and targeted interventions aimed at supporting countries in reducing the risk of HIV infection and transmission among, and ensuring adequate and accessible health care for, transgender people deprived of liberty by State authorities in prisons and other closed settings. Policymakers and prison authorities should understand the needs of transgender people and incorporate the proposed evidence- and human rights-based interventions and international standards into their prison policies and strategies, applying them to all people in prison.  

WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resistance in adults, children and adolescents receiving dolutegravir-based ART. This sentinel method is implemented complementary to WHO-recommended methods for estimating nationally representative levels of acquired HIV drug resistance. 

In this guideline, WHO recommends that long-acting injectable cabotegravir (CAB-LA) may be offered as an additional HIV prevention option for people at substantial risk of HIV infection. CAB-LA is an injectable form of pre-exposure prophylaxis (PrEP) that has been shown to be highly effective at reducing the risk of HIV acquisition. This guideline provides implementation considerations to support Member States, programme managers, policy makers, researchers, health workers, communities, and other stakeholders in the implementation of projects and programmes for CAB-LA. It also outlines critical research gaps for CAB-LA.

This publication is primarily intended for national and local policy-makers; global, regional, country and local programme implementers; organizations working in and providers of health, HIV, mental health and other relevant services; civil society; and community-based and community-led organizations and advocates. It brings together and refers to existing HIV and mental health, psychosocial support and other service provision guidelines, recommendations and tools, including the World Health Organization (WHO) Mental Health Gap Action Programme (mhGAP) mhGAP intervention guide and mhGAP operations manual; WHO, United Nations Office on Drugs and Crime and other guidelines and tools related to substance use; and WHO consolidated guidelines, tools and resources on HIV testing, prevention, treatment and care.

This information brief is intended for key population networks and other community-led and community-based organizations to help them better understand how to request funding support for community-led monitoring (CLM) in 2023-2025 applications to the Global Fund. The brief has been jointly developed by TREAT Asia/amfAR and the International Treatment Preparedness Coalition (ITPC).

Press conference for global launch of Dangerous Inequalities, ahead of World AIDS Day from Dar es Salaam, Tanzania.

This report, which marks World AIDS Day 2022, unpacks the impact that gender inequalities, inequalities faced by key populations, and inequalities between children and adults have had on the AIDS response. It is not inevitable, however, that these inequalities will slow progress towards ending AIDS. We know what works—with courage and cooperation, political leaders can tackle them.

Tuberculosis profiles are generated automatically based on data reported by countries and which are held in WHO's global TB database. The document includes data for estimates of TB burden, UHC and social protection, TB/HIV care in new and relapse TB patients, drug-resistant TB care in the country.

Tuberculosis profiles are generated automatically based on data reported by countries and which are held in WHO's global TB database. The document includes data for estimates of TB burden, UHC and social protection, TB/HIV care in new and relapse TB patients, drug-resistant TB care in the country.